Pure Global AI
NCT06114901Not yet recruiting

Efficacy of Mobile-delivered Sleep Restriction Therapy for Treatment of Insomnia Disorder: Randomised Controlled Trial

Woolcock Institute of Medical ResearchClinicalTrials.govother
Verified
Study focus
Disease/Condition
Insomnia
Drug/Device/Intervention
SleepFix
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Woolcock Institute of Medical Research
Location
Sydney, Australia
Timeline & enrollment
Phase
N/A
Start date
Nov 10, 2023
End date
Oct 26, 2028
Enrollment
558 participants
Primary outcome

Insomnia symptom severity

Summary

The SleepFix Study is a clinical trial designed to evaluate the efficacy of
 mobile-delivered sleep restriction therapy (dBTi) in comparison to digital sleep health
 education (control) for treating insomnia disorder in adults aged 18 and above. The study is
 conducted entirely online, with 558 participants (279 in each group) and aims to determine
 the impact of the interventions on insomnia symptom severity, sleep metrics, subjective sleep
 quality, fatigue, anxiety, depressive symptoms, quality of life, medication usage, and
 workforce productivity.

ICD-10 classifications
Nonorganic insomniaDisorders of initiating and maintaining sleep [insomnias]Sleep disordersSleep disorder, unspecifiedOther sleep disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06114901
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06114901 through Pure Global AI's free database. This phase not specified trial is sponsored by Woolcock Institute of Medical Research and is currently Not yet recruiting. The study focuses on Insomnia. Target enrollment is 558 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.